Celularity (CELU) Net Margin (2020 - 2026)
Celularity (CELU) recorded Net Margin of -594.23% in Q4 2025, down 520.92 percentage points from -73.30% a year earlier and down 157.57 percentage points from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Net Margin (2020 - 2026) Analysis & Trends
For FY2025, Celularity reported Net Margin of -345.76%, down 238.99 percentage points from FY2024.
- Annual Net Margin has a five-year change of +1112.66 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -106.77% in FY2024 (+755.27 pp), -862.04% in FY2023 (-940.99 pp), 78.95% in FY2022 (+548.22 pp) and -469.27% in FY2021 (+989.15 pp).
- The Q4 2025 figure is the lowest quarterly Net Margin since Q3 2023.
- On a year-over-year basis, Net Margin has declined for five consecutive quarters, with an average year-over-year change of +503.47 percentage points over the last eight quarters.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 3283.38 percentage points in Q2 2022, against a drop of 2898.61 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -436.66% (Q3 2025), -427.60% (Q2 2025) and -173.40% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 32.99% |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | 17.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 17.55% |
| Dec 31, 2025 | -594.23% |
| Sep 30, 2025 | -436.66% |
| Jun 30, 2025 | -427.60% |
| Mar 31, 2025 | -173.40% |
| Dec 31, 2024 | -73.30% |
| Sep 30, 2024 | -173.19% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -149.94% |
| Dec 31, 2023 | 78.82% |
| Sep 30, 2023 | -2,479.56% |
| Jun 30, 2023 | -1,632.03% |
| Mar 31, 2023 | -1,626.86% |
| Dec 31, 2022 | 591.77% |
| Sep 30, 2022 | 116.06% |
| Jun 30, 2022 | 1,266.58% |
| Mar 31, 2022 | -1,059.26% |
| Dec 31, 2021 | -83.20% |
| Sep 30, 2021 | 470.14% |
| Jun 30, 2021 | -2,016.80% |
API Access
Celularity Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();